- Home
- RIGL vs ASG Comparison
RIGL vs ASG Comparison
Compare RIGL & ASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- ASG
- Stock Information
- Founded
- RIGL 1996
- ASG 1986
- Country
- RIGL United States
- ASG United States
- Employees
- RIGL N/A
- ASG N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- ASG Investment Managers
- Sector
- RIGL Health Care
- ASG Finance
- Exchange
- RIGL Nasdaq
- ASG Nasdaq
- Market Cap
- RIGL 335.5M
- ASG 327.8M
- IPO Year
- RIGL 2000
- ASG N/A
- Fundamental
- Price
- RIGL $38.85
- ASG $5.55
- Analyst Decision
- RIGL Buy
- ASG
- Analyst Count
- RIGL 5
- ASG 0
- Target Price
- RIGL $38.20
- ASG N/A
- AVG Volume (30 Days)
- RIGL 995.6K
- ASG 324.3K
- Earning Date
- RIGL 08-05-2025
- ASG 01-01-0001
- Dividend Yield
- RIGL N/A
- ASG 8.09%
- EPS Growth
- RIGL N/A
- ASG N/A
- EPS
- RIGL 5.43
- ASG N/A
- Revenue
- RIGL $267,921,000.00
- ASG N/A
- Revenue This Year
- RIGL $59.93
- ASG N/A
- Revenue Next Year
- RIGL N/A
- ASG N/A
- P/E Ratio
- RIGL $7.15
- ASG N/A
- Revenue Growth
- RIGL 105.62
- ASG N/A
- 52 Week Low
- RIGL $12.66
- ASG $4.47
- 52 Week High
- RIGL $43.72
- ASG $5.71
- Technical
- Relative Strength Index (RSI)
- RIGL 68.57
- ASG 56.82
- Support Level
- RIGL $39.00
- ASG $5.36
- Resistance Level
- RIGL $42.08
- ASG $5.51
- Average True Range (ATR)
- RIGL 2.32
- ASG 0.06
- MACD
- RIGL -0.37
- ASG 0.01
- Stochastic Oscillator
- RIGL 53.26
- ASG 76.00
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About ASG Liberty All-Star Growth Fund Inc.
Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.